As of Friday, February 06, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 6.36%, which has investors questioning ...
The FDA grants Fast Track designation to sonelokimab for moderate to severe palmoplantar pustulosis, a chronic inflammatory skin disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results